The softer sales, along with reimbursement pressure in wound care, caused the London-based company to miss Wall Street ...

Understanding the realities patients face when using devices outside the hospital requires, well, getting out of the hospital ...

Examine how to architect intensive real-time control, high-resolution vision, AI inference, visualization, and data capture ...

Guardant Health's Shield blood test wins the 2026 Prix Galien USA Award for Best Medical Technology, recognizing its impact ...

Draeger, BD, Edwards, Philips, Cardinal Health, Medline, and Nova Biomedical issued major recalls in October 2026 after ...

Boston Scientific's SIMPLAAFY data show aspirin alone or reduced-dose anticoagulation matches DAPT after Watchman Flx Pro ...

Edwards Lifesciences raised its 2026 guidance for the third time this year, citing strong TAVR growth, new clinical data, and ...

Boston Scientific cuts Q4 guidance as cyberattack fallout and EP and Watchman market pressures weigh on growth heading into ...

Cochlear completes pivotal trial enrollment for its fully implantable hearing device. CTO shares insights on design, safety, ...

Edwards' PROGRESS Trial found TAVR cut death or heart failure risk by a third versus surveillance in moderate aortic stenosis patients at TCT 2026.

Democrats' new House and Senate majority could reshape drug pricing, ACA subsidies, and healthcare oversight heading into ...